Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome

被引:222
作者
Fiser, SM [1 ]
Tribble, CG [1 ]
Long, SM [1 ]
Kaza, AK [1 ]
Kern, JA [1 ]
Jones, DR [1 ]
Robbins, MK [1 ]
Kron, IL [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Thorac & Cardiovasc Surg, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA
关键词
D O I
10.1016/S0003-4975(01)03606-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Bronchiolitis obliterans syndrome (BOS) is the most common cause of long-term morbidity and mortality after lung transplantation. Our hypothesis was that early ischemia-reperfusion injury after lung transplantation increases the risk of BOS. Methods. Data on 134 patients who had lung transplantation between January 1, 1990 and January 1, 2000, was used for univariate and multivariate logistic regression analysis. Results. After lung transplantation, 115 patients (115 of 134, 86%) survived more than 3 months. In that group, 41 patients developed BOS, of which 23 had progressive disease. Univariate analysis revealed that ischemia-reperfusion injury (p = 0.017) and two or more acute rejection episodes (p = 0.032) were predictors of BOS onset, whereas ischemia-reperfusion injury (p = 0.011) and cytomegalovirus infection (p = 0.009), predicted progressive BOS. Multivariate logistic regression analysis showed that ischemia-reperfusion injury was an independent predictor for both BOS development and BOS progression. Two or more acute rejection episodes were also an independent predictor of BOS development, whereas cytomegalovirus infection was an independent predictor of progressive BOS. Conclusions. Ischemia-reperfusion injury increases the risk of BOS after lung transplantation. (C) 2002 by The Society of Thoracic Surgeons.
引用
收藏
页码:1041 / 1047
页数:7
相关论文
共 34 条
  • [1] OBLITERATIVE BRONCHIOLITIS AFTER LUNG AND HEART-LUNG TRANSPLANTATION - AN ANALYSIS OF RISK-FACTORS AND MANAGEMENT
    BANDO, K
    PARADIS, IL
    SIMILO, S
    KONISHI, H
    KOMATSU, K
    ZULLO, TG
    YOUSEM, SA
    CLOSE, JM
    ZEEVI, A
    DUQUESNOY, RJ
    MANZETTI, J
    KEENAN, RJ
    ARMITAGE, JM
    HARDESTY, RL
    GRIFFITH, BP
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) : 4 - 14
  • [2] COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713
  • [3] RESULTS OF SINGLE AND BILATERAL LUNG TRANSPLANTATION IN 131 CONSECUTIVE RECIPIENTS
    COOPER, JD
    PATTERSON, A
    TRULOCK, EP
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) : 460 - 471
  • [4] Eppinger MJ, 1997, AM J PATHOL, V150, P1773
  • [5] CYTOMEGALOVIRUS-INFECTION AND PNEUMONITIS - IMPACT AFTER ISOLATED LUNG TRANSPLANTATION
    ETTINGER, NA
    BAILEY, TC
    TRULOCK, EP
    STORCH, GA
    ANDERSON, D
    RAAB, S
    SPITZNAGEL, EL
    DRESLER, C
    COOPER, JD
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : 1017 - 1023
  • [6] Influence of graft ischemic time on outcomes following lung transplantation
    Fiser, SM
    Kron, IL
    Long, SM
    Kaza, AK
    Kern, JA
    Cassada, DC
    Jones, DR
    Robbins, MC
    Tribble, CG
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (12) : 1291 - 1296
  • [7] Early intervention after severe oxygenation index elevation improves survival following lung transplantation
    Fiser, SM
    Kron, IL
    Long, SM
    Kaza, AK
    Kern, JA
    Tribble, CG
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (06) : 631 - 636
  • [8] Girgis RE, 1996, J HEART LUNG TRANSPL, V15, P1200
  • [9] IMMUNOLOGICALLY MEDIATED DISEASE OF THE AIRWAYS AFTER PULMONARY TRANSPLANTATION
    GRIFFITH, BP
    PARADIS, IL
    ZEEVI, A
    RABINOWICH, H
    YOUSEM, SA
    DUQUESNOY, RJ
    DAUBER, JH
    HARDESTY, RL
    [J]. ANNALS OF SURGERY, 1988, 208 (03) : 371 - 378
  • [10] Halloran PF, 1996, J HEART LUNG TRANSPL, V15, P959